Page 3 - Laurus Labs

Laurus Labs shares advance 5% on strong growth outlook

Laurus is well poised to follow the success story of some leading CDMO players backed by strong chemistry and integrated model

Laurus Labs hits new high in subdued market, surges 30% in a month

The company is scheduled to meet on April 29, 2021, to consider and approve the audited financial results of the company for the financial year ended March 31, 2021

Laurus Labs rallies 6%, hits record high on heavy volume

The pharmaceutical company's stock surpassed its previous high of Rs 386, touched on January 25, 2021

Dixon Tech, Adani Green: How to trade multi-baggers of FY21 in new fiscal

Hindustan Copper, Aarti Drugs, Dixon Technology, APL Apollo Tubes, Laurus Labs and Affle India, meanwhile, zoomed over 400 per cent during FY21

Laurus Labs falls 5% as promoters sell 1.3% stake in company

Laurus Labs said the significant part of the above amount shall be utilized to release the pledge on their equity shares of the company

Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high

Healthcare companies to post decent growth in revenues in Q3FY21

BSE Healthcare index hits new high; Sun Pharma, Laurus Labs gain up to 5%

Sun Pharmaceutical Industries hit afresh 52-week high of Rs 568.50, up nearly 4 per cent in the intra-day trade today. It has surged 11 per cent in the past four trading days on the BSE

Surprise amid pandemic: Firms across sectors beat Q2 earnings expectations

Most brokerages have revised upwards their earnings estimates, not only for FY21, but also for FY22

Laurus Labs gains 7% in two days on acquisition of Richcore Lifesciences

Motilal Oswal Securities maintains 'buy' rating on Laurus Labs with target price of Rs 410 per share

Laurus Labs gains 5% on acquisition of Richcore Lifesciences

Laurus Labs has signed a definitive agreement to acquire 72.55 per cent of Richcore's shares from Eight Roads Ventures and VenturEast for a value of Rs. 246.7 crore

Laurus Labs inks deal to buy majority stake in Richcore for Rs 247 crore

Following the successful closure of thetransaction, Richcore will be renamed as Laurus Bio Pvt Ltd, it added

Street rewards all but one of 12 companies that pruned share pledges

Sequent Scientific and Everyday Industries saw percentage shareholding pledged by promoters go down by over 44 per cent each and their shares rally by 68 per cent and 75 per cent, respectively

Adani Green Energy, Laurus Labs among top value creators in Samvat 2076

Meanwhile, Dr Reddy's Laboratories, Cipla, Infosys, HCL Technologies were up between 25 per cent and 75 per cent.

Laurus Labs extends fall for fourth straight day, dips 21% from record high

The company's profit after tax (PAT) was up 328 per cent year-on-year (YoY) at Rs 242 crore.

Street signs: Market trend turns weak, Laurus Labs stock rises, and more

After a sustained bull run, the markets are expected to enter a turbulent period

Top headlines: US court asks Isro arm to pay, Apple clocks record sales

From Apple selling record iPhones in Sept quarter in India to govt making first set of draft rules under labour code public, Business Standard brings you top news of the evening

With 350% stock gain, drugmaker Laurus Labs seeks to boost capacity

The pharmaceutical sector is the top performer in India's $2.1 trillion equity market this year after the coronavirus pandemic turned global investors' spotlight on health-care companies

Laurus Labs hits record high on robust September quarter results

The company's Ebitda margins improved 1,349 basis points to 32.8 per cent due to better product mix and improved operating leverage

Laurus Labs surges 6% as stock to turn ex-date for 1:5 split on Tuesday

The board has fixed September 30, 2020 as the 'record date' for sub-division of equity shares of the company from existing face value of Rs 10 each to face value of Rs 2 each

BSE Healthcare index hits record high; Laurus Labs, Dr Reddy's at new highs

Lupin, Stride Pharma, Neuland Labs, Lincoln Pharma, and Hikal hit their respective 52-week highs on the BSE